NOI TO SOLE SOURCE TO ONE LAMBDA, INC.

The purpose of this acquisition is to provide HLA typing and antibody screening reagents to the HLA Lab on a regular basis.  One Lambda (vendor) will ship reagents included on the quote on an “as needed/requested” basis. Vendor will provide the reagents within 1 week, unless otherwise specified during ordering.

•             Product Service Code: 6640 – Laboratory Equipment and Supplies

•             NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing

•             Place of Performance: NIH Clinical Center, Bethesda, MD 20892 USA

POTS: 26-000027

Description:

This is a notice of intent, not a request for a quotation.  A solicitation document will not be issued, and quotations will not be requested.

The National Institutes of Health (NIH) intends to award a one-year contract to One Lambda Inc., located at 22801 Roscoe Blvd, West Hills, CA 91304, on a firm fixed price sole source award basis for the purchase of Reagents for HLA Typing and Antibody Screening of NIH Transplant Protocols.

The proposed vendor, One Lambda Inc., is the only manufacturer of these specific HLA typing and antibody screening reagents. The HLA Lab currently uses these reagents to test our patients.  The reagents provided by One Lambda have been previously tested in the lab and provide a greater ability to resolve testing ambiguities than other vendors tested.  All validation testing has been completed for these reagents so there is laboratory documentation available to confirm the accuracy and precision of these reagents.  A change in vendors/reagents would require extensive validation and would take approximately 2 months.  This would greatly impact the ability of the HLA Lab to provide timely results.

This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available.  Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.

The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.

Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Huda Malik, Contract Specialist via email to huda.malik@nih.gov by May 27, 2026 by 10 am EST.